Clinical trials
Completed Phase 1 Neuroinflammatory Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2009 | 1 |
| 2016 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 2 |
| National Institute of Mental Health (NIMH) | 2 |
| Contineum Therapeutics | 1 |
| Monument Therapeutics Limited | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroinflammatory Diseases | 7 |
| Epilepsy | 2 |
| Multiple Sclerosis | 2 |
| Neurocysticercosis | 2 |
| Taeniasis | 2 |
| Alzheimer Disease | 1 |
| Autoimmune Diseases | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Demyelinating Autoimmune Diseases, CNS | 1 |
| Demyelinating Diseases | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.